Global Covid-19 Vaccine Market Research Report 2023

Publisher Name :
Date: 10-Jan-2023
No. of pages: 89
Inquire Before Buying

This report aims to provide a comprehensive presentation of the global market for Covid-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Vaccine.

The Covid-19 Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Covid-19 Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Moderna

- CanSino Biologicals

- Inovio Pharmaceuticals

- Shenzhen Geno-Immune Medical Institute

- GlaxoSmithKine

- Pfizer

- Johnson&Johnson

- Heat Biologics

- Sanofi

Segment by Type

- DNA

- Non-replicating Viral Vector

- Protein Subunit

- RNA

- Others

Segment by Application

- Adults

- Children

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Covid-19 Vaccine companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Covid-19 Vaccine Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Vaccine Market Perspective (2018-2029)
2.2 Covid-19 Vaccine Growth Trends by Region
2.2.1 Global Covid-19 Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Covid-19 Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Covid-19 Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Covid-19 Vaccine Market Dynamics
2.3.1 Covid-19 Vaccine Industry Trends
2.3.2 Covid-19 Vaccine Market Drivers
2.3.3 Covid-19 Vaccine Market Challenges
2.3.4 Covid-19 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Vaccine Players by Revenue
3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2018-2023)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Vaccine Revenue
3.4 Global Covid-19 Vaccine Market Concentration Ratio
3.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2022
3.5 Covid-19 Vaccine Key Players Head office and Area Served
3.6 Key Players Covid-19 Vaccine Product Solution and Service
3.7 Date of Enter into Covid-19 Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Vaccine Breakdown Data by Type
4.1 Global Covid-19 Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2024-2029)
5 Covid-19 Vaccine Breakdown Data by Application
5.1 Global Covid-19 Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Covid-19 Vaccine Market Size (2018-2029)
6.2 North America Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Covid-19 Vaccine Market Size by Country (2018-2023)
6.4 North America Covid-19 Vaccine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Vaccine Market Size (2018-2029)
7.2 Europe Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Covid-19 Vaccine Market Size by Country (2018-2023)
7.4 Europe Covid-19 Vaccine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Covid-19 Vaccine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Covid-19 Vaccine Market Size by Region (2018-2023)
8.4 Asia-Pacific Covid-19 Vaccine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Vaccine Market Size (2018-2029)
9.2 Latin America Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Covid-19 Vaccine Market Size by Country (2018-2023)
9.4 Latin America Covid-19 Vaccine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Covid-19 Vaccine Market Size by Country (2018-2023)
10.4 Middle East & Africa Covid-19 Vaccine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Detail
11.1.2 Moderna Business Overview
11.1.3 Moderna Covid-19 Vaccine Introduction
11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2018-2023)
11.1.5 Moderna Recent Development
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Detail
11.2.2 CanSino Biologicals Business Overview
11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2018-2023)
11.2.5 CanSino Biologicals Recent Development
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Detail
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2018-2023)
11.3.5 Inovio Pharmaceuticals Recent Development
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Detail
11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2018-2023)
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Detail
11.5.2 GlaxoSmithKine Business Overview
11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2018-2023)
11.5.5 GlaxoSmithKine Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Covid-19 Vaccine Introduction
11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Johnson?Johnson
11.7.1 Johnson?Johnson Company Detail
11.7.2 Johnson?Johnson Business Overview
11.7.3 Johnson?Johnson Covid-19 Vaccine Introduction
11.7.4 Johnson?Johnson Revenue in Covid-19 Vaccine Business (2018-2023)
11.7.5 Johnson?Johnson Recent Development
11.8 Heat Biologics
11.8.1 Heat Biologics Company Detail
11.8.2 Heat Biologics Business Overview
11.8.3 Heat Biologics Covid-19 Vaccine Introduction
11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2018-2023)
11.8.5 Heat Biologics Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Covid-19 Vaccine Introduction
11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2018-2023)
11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of DNA
Table 3. Key Players of Non-replicating Viral Vector
Table 4. Key Players of Protein Subunit
Table 5. Key Players of RNA
Table 6. Key Players of Others
Table 7. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Covid-19 Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Covid-19 Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Covid-19 Vaccine Market Share by Region (2018-2023)
Table 11. Global Covid-19 Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Covid-19 Vaccine Market Share by Region (2024-2029)
Table 13. Covid-19 Vaccine Market Trends
Table 14. Covid-19 Vaccine Market Drivers
Table 15. Covid-19 Vaccine Market Challenges
Table 16. Covid-19 Vaccine Market Restraints
Table 17. Global Covid-19 Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Covid-19 Vaccine Market Share by Players (2018-2023)
Table 19. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2022)
Table 20. Ranking of Global Top Covid-19 Vaccine Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Covid-19 Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Covid-19 Vaccine Product Solution and Service
Table 24. Date of Enter into Covid-19 Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Covid-19 Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Covid-19 Vaccine Revenue Market Share by Type (2018-2023)
Table 28. Global Covid-19 Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Covid-19 Vaccine Revenue Market Share by Type (2024-2029)
Table 30. Global Covid-19 Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Covid-19 Vaccine Revenue Market Share by Application (2018-2023)
Table 32. Global Covid-19 Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Covid-19 Vaccine Revenue Market Share by Application (2024-2029)
Table 34. North America Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Covid-19 Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Covid-19 Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Covid-19 Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Covid-19 Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Covid-19 Vaccine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Covid-19 Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Covid-19 Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Covid-19 Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Covid-19 Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Covid-19 Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Covid-19 Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 49. Moderna Company Detail
Table 50. Moderna Business Overview
Table 51. Moderna Covid-19 Vaccine Product
Table 52. Moderna Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 53. Moderna Recent Development
Table 54. CanSino Biologicals Company Detail
Table 55. CanSino Biologicals Business Overview
Table 56. CanSino Biologicals Covid-19 Vaccine Product
Table 57. CanSino Biologicals Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 58. CanSino Biologicals Recent Development
Table 59. Inovio Pharmaceuticals Company Detail
Table 60. Inovio Pharmaceuticals Business Overview
Table 61. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 62. Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 63. Inovio Pharmaceuticals Recent Development
Table 64. Shenzhen Geno-Immune Medical Institute Company Detail
Table 65. Shenzhen Geno-Immune Medical Institute Business Overview
Table 66. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 67. Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 68. Shenzhen Geno-Immune Medical Institute Recent Development
Table 69. GlaxoSmithKine Company Detail
Table 70. GlaxoSmithKine Business Overview
Table 71. GlaxoSmithKine Covid-19 Vaccine Product
Table 72. GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 73. GlaxoSmithKine Recent Development
Table 74. Pfizer Company Detail
Table 75. Pfizer Business Overview
Table 76. Pfizer Covid-19 Vaccine Product
Table 77. Pfizer Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Johnson?Johnson Company Detail
Table 80. Johnson?Johnson Business Overview
Table 81. Johnson?Johnson Covid-19 Vaccine Product
Table 82. Johnson?Johnson Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 83. Johnson?Johnson Recent Development
Table 84. Heat Biologics Company Detail
Table 85. Heat Biologics Business Overview
Table 86. Heat Biologics Covid-19 Vaccine Product
Table 87. Heat Biologics Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 88. Heat Biologics Recent Development
Table 89. Sanofi Company Detail
Table 90. Sanofi Business Overview
Table 91. Sanofi Covid-19 Vaccine Product
Table 92. Sanofi Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Vaccine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Covid-19 Vaccine Market Share by Type: 2022 VS 2029
Figure 3. DNA Features
Figure 4. Non-replicating Viral Vector Features
Figure 5. Protein Subunit Features
Figure 6. RNA Features
Figure 7. Others Features
Figure 8. Global Covid-19 Vaccine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Covid-19 Vaccine Market Share by Application: 2022 VS 2029
Figure 10. Adults Case Studies
Figure 11. Children Case Studies
Figure 12. Covid-19 Vaccine Report Years Considered
Figure 13. Global Covid-19 Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Covid-19 Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Covid-19 Vaccine Market Share by Region: 2022 VS 2029
Figure 16. Global Covid-19 Vaccine Market Share by Players in 2022
Figure 17. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2022
Figure 19. North America Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Covid-19 Vaccine Market Share by Country (2018-2029)
Figure 21. United States Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Covid-19 Vaccine Market Share by Country (2018-2029)
Figure 25. Germany Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Covid-19 Vaccine Market Share by Region (2018-2029)
Figure 33. China Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Covid-19 Vaccine Market Share by Country (2018-2029)
Figure 41. Mexico Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Covid-19 Vaccine Market Share by Country (2018-2029)
Figure 45. Turkey Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Covid-19 Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Moderna Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 48. CanSino Biologicals Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 49. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 50. Shenzhen Geno-Immune Medical Institute Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 51. GlaxoSmithKine Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 53. Johnson?Johnson Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 54. Heat Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 55. Sanofi Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs